Allen Patricia L
Insider CIK 1348587 · ZFGN Chief Financial Officer · YMTX Director · DCPH Director · ZBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2026-06-15 | 2026-06-17 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-02-13 | 2026-02-13 | 4,160 | $26.36 | $109.7K | 19,860 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-02-12 | 2026-02-13 | 5,000 | $26.50 | $132.5K | 15,700 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-02-12 | 2026-02-13 | 5,000 | $23.77 | $118.8K | 5,000 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2026-02-12 | 2026-02-13 | 5,700 | $24.34 | $138.7K | 10,700 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 9,570 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 30,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 3,269 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 18,500 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 4,727 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 12,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 7,181 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 10,233 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2024-01-16 | 2024-01-18 | 4,727 | $10.58 | $50.0K | 4,727 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-06-21 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-01-17 | 2023-01-19 | 3,269 | $15.30 | $50.0K | 3,269 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-06-23 | 2022-06-24 | 18,500 | — | $0 | 18,500 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-01-18 | 2022-01-20 | 9,570 | $5.22 | $50.0K | 9,570 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-06-23 | 2021-06-25 | 12,000 | — | $0 | 12,000 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2021-06-02 | 2021-06-04 | 14,800 | — | $0 | 14,800 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 5,271 | — | $0 | 5,271 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 12,495 | — | $0 | 12,495 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-06-10 | 2020-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-06-05 | 2020-06-05 | 5,635 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-06-05 | 2020-06-05 | 5,635 | $55.90 | $315.0K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-06-05 | 2020-06-05 | 5,635 | $25.73 | $145.0K | 5,635 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-06-03 | 2020-06-05 | 6,365 | — | $0 | 5,635 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-06-03 | 2020-06-05 | 6,365 | $59.14 | $376.4K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-06-03 | 2020-06-05 | 6,365 | $25.73 | $163.8K | 6,365 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-01-24 | 2020-01-28 | 25,000 | — | $0 | 10,233 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-24 | 2020-01-28 | 700 | $67.36 | $47.2K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-24 | 2020-01-28 | 6,496 | $66.55 | $432.3K | 700 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2020-01-24 | 2020-01-28 | 17,804 | $65.93 | $1.17M | 7,196 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | C Conversion | 2020-01-24 | 2020-01-28 | 25,000 | $3.95 | $98.8K | 25,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-06-11 | 2019-06-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 125,000 | — | $0 | 125,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2018-05-17 | 2018-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2018-02-22 | 2018-02-23 | 125,000 | — | $0 | 125,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 35,233 | — | $0 | 35,233 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 1,271 | — | $0 | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 7,181 | — | $0 | 7,181 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2017-10-02 | 2017-10-02 | 6,236 | — | $0 | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2017-01-27 | 2017-01-31 | 88,000 | — | $0 | 88,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-07-26 | 2016-07-26 | 8,200 | $3.15 | $25.8K | 19,793 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-07-25 | 2016-07-26 | 7,800 | $3.08 | $24.0K | 11,593 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-03-31 | 2016-04-04 | 72,000 | — | $0 | 72,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-03-31 | 2016-04-04 | 36,000 | — | $0 | 36,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2015-02-27 | 2015-03-03 | 60,000 | — | $0 | 187,388 | SEC↗ |